Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients

Background In metastatic melanoma, 40%-50% of patients harbor a BRAF V600E mutation and are thereby eligible to receive a combined BRAF / MEK inhibitor therapy. Compared to standard-of-care tissue-based genetic testing, analysis of circulating tumor DNA (ctDNA) from blood enables a comprehensive ass...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tzanikou, Eleni (VerfasserIn) , Haselmann, Verena (VerfasserIn) , Markou, Athina (VerfasserIn) , Duda, Angelika (VerfasserIn) , Utikal, Jochen (VerfasserIn) , Neumaier, Michael (VerfasserIn) , Lianidou, Evi S. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18. Januar 2020
In: Clinical chemistry and laboratory medicine
Year: 2020, Jahrgang: 58, Heft: 11, Pages: 1799-1807
ISSN:1437-4331
DOI:10.1515/cclm-2019-0783
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1515/cclm-2019-0783
Verlag, lizenzpflichtig, Volltext: https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-0783/html
Volltext
Verfasserangaben:Eleni Tzanikou, Verena Haselmann, Athina Markou, Angelika Duda, Jochen Utikal, Michael Neumaier, Evi S. Lianidou

MARC

LEADER 00000caa a22000002c 4500
001 1897800495
003 DE-627
005 20250530002947.0
007 cr uuu---uuuuu
008 240805s2020 xx |||||o 00| ||eng c
024 7 |a 10.1515/cclm-2019-0783  |2 doi 
035 |a (DE-627)1897800495 
035 |a (DE-599)KXP1897800495 
035 |a (OCoLC)1475305438 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tzanikou, Eleni  |e VerfasserIn  |0 (DE-588)1337925853  |0 (DE-627)1897800347  |4 aut 
245 1 0 |a Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients  |c Eleni Tzanikou, Verena Haselmann, Athina Markou, Angelika Duda, Jochen Utikal, Michael Neumaier, Evi S. Lianidou 
264 1 |c 18. Januar 2020 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.08.2024 
520 |a Background In metastatic melanoma, 40%-50% of patients harbor a BRAF V600E mutation and are thereby eligible to receive a combined BRAF / MEK inhibitor therapy. Compared to standard-of-care tissue-based genetic testing, analysis of circulating tumor DNA (ctDNA) from blood enables a comprehensive assessment of tumor mutational status in real-time and can be used for monitoring response to therapy. The aim of our study was to directly compare the performance of two highly sensitive methodologies, droplet digital PCR (ddPCR) and a combination of ARMS/asymmetric-rapid PCR/melting curve analysis, for the detection of BRAF V600E in plasma from melanoma patients. Methods Cell-free DNA (cfDNA) was isolated from 120 plasma samples of stage I to IV melanoma patients. Identical plasma-cfDNA samples were subjected to BRAF V600E mutational analysis using in parallel, ddPCR and the combination of ARMS/asymmetric-rapid PCR/melting curve analysis. Results BRAF V600E mutation was detected in 9/117 (7.7%) ctDNA samples by ddPCR and in 22/117 (18.8%) ctDNA samples by the combination of ARMS/asymmetric- rapid PCR/melting curve analysis. The concordance between these two methodologies was 85.5% (100/117). The comparison of plasma-ctDNA analysis using ddPCR and tissue testing revealed an overall agreement of 79.4% (27/34), while the corresponding agreement using the combination of ARMS/asymmetric-rapid PCR/melting curve analysis was 73.5% (25/34). Moreover, comparing the detection of BRAF- mutant ctDNA with the clinics, overall agreement of 87.2% (48/55) for ddPCR and 79.2% (42/53) was demonstrated. Remarkably, the duration of sample storage was negatively correlated with correctness of genotyping results highlighting the importance of pre-analytical factors. Conclusions Our direct comparison study has shown a high level of concordance between ddPCR and the combination of ARMS/asymmetric-rapid PCR/melting curve analysis for the detection of BRAF V600E mutations in plasma. 
650 4 |a BRAF mutation 
650 4 |a ctDNA analysis 
650 4 |a liquid biopsy 
650 4 |a melanoma 
650 4 |a plasma 
700 1 |a Haselmann, Verena  |d 1982-  |e VerfasserIn  |0 (DE-588)1153803097  |0 (DE-627)1015321275  |0 (DE-576)500568154  |4 aut 
700 1 |a Markou, Athina  |e VerfasserIn  |4 aut 
700 1 |a Duda, Angelika  |e VerfasserIn  |0 (DE-588)1114508306  |0 (DE-627)868711764  |0 (DE-576)477356311  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
700 1 |a Neumaier, Michael  |d 1958-  |e VerfasserIn  |0 (DE-588)1028284934  |0 (DE-627)730532623  |0 (DE-576)375780580  |4 aut 
700 1 |a Lianidou, Evi S.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical chemistry and laboratory medicine  |d Berlin [u.a.] : De Gruyter, 1998  |g 58(2020), 11, Seite 1799-1807  |h Online-Ressource  |w (DE-627)302923187  |w (DE-600)1492732-9  |w (DE-576)088704882  |x 1437-4331  |7 nnas  |a Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients 
773 1 8 |g volume:58  |g year:2020  |g number:11  |g pages:1799-1807  |g extent:9  |a Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients 
856 4 0 |u https://doi.org/10.1515/cclm-2019-0783  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-0783/html  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240805 
993 |a Article 
994 |a 2020 
998 |g 1028284934  |a Neumaier, Michael  |m 1028284934:Neumaier, Michael  |d 60000  |d 63300  |e 60000PN1028284934  |e 63300PN1028284934  |k 0/60000/  |k 1/60000/63300/  |p 6 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 5 
998 |g 1114508306  |a Duda, Angelika  |m 1114508306:Duda, Angelika  |d 60000  |d 63300  |e 60000PD1114508306  |e 63300PD1114508306  |k 0/60000/  |k 1/60000/63300/  |p 4 
998 |g 1153803097  |a Haselmann, Verena  |m 1153803097:Haselmann, Verena  |d 60000  |e 60000PH1153803097  |k 0/60000/  |p 2 
999 |a KXP-PPN1897800495  |e 4562890568 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"18. Januar 2020","dateIssuedKey":"2020"}],"note":["Gesehen am 05.08.2024"],"title":[{"title_sort":"Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients","title":"Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Eleni Tzanikou, Verena Haselmann, Athina Markou, Angelika Duda, Jochen Utikal, Michael Neumaier, Evi S. Lianidou"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"titleAlt":[{"title":"CCLM"}],"part":{"extent":"9","volume":"58","year":"2020","pages":"1799-1807","text":"58(2020), 11, Seite 1799-1807","issue":"11"},"language":["eng"],"id":{"eki":["302923187"],"doi":["10.1515/cclm"],"issn":["1437-4331"],"zdb":["1492732-9"]},"name":{"displayForm":["publ. in association with the International Federation of Clinical Chemistry and Laboratory Medicine and the Forum of the European Societies of Clinical Chemistry"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"302923187","disp":"Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patientsClinical chemistry and laboratory medicine","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 22.6.2022"],"origin":[{"publisherPlace":"Berlin [u.a.]","dateIssuedDisp":"1998-","dateIssuedKey":"1998","publisher":"De Gruyter"}],"pubHistory":["36.1998-"],"title":[{"title_sort":"Clinical chemistry and laboratory medicine","title":"Clinical chemistry and laboratory medicine"}]}],"recId":"1897800495","id":{"eki":["1897800495"],"doi":["10.1515/cclm-2019-0783"]},"person":[{"display":"Tzanikou, Eleni","family":"Tzanikou","role":"aut","given":"Eleni"},{"display":"Haselmann, Verena","family":"Haselmann","role":"aut","given":"Verena"},{"display":"Markou, Athina","family":"Markou","given":"Athina","role":"aut"},{"role":"aut","given":"Angelika","family":"Duda","display":"Duda, Angelika"},{"family":"Utikal","display":"Utikal, Jochen","given":"Jochen","role":"aut"},{"family":"Neumaier","display":"Neumaier, Michael","given":"Michael","role":"aut"},{"given":"Evi S.","role":"aut","family":"Lianidou","display":"Lianidou, Evi S."}],"language":["eng"]} 
SRT |a TZANIKOUELDIRECTCOMP1820